Panel Discussion: Clinical Trials in a Dish? Modeling Neurodegenerative Disease with iPSCs

This thought-leading panel discussion highlighted the benefits and challenges of using iPSCs in global R&D for neurodegenerative disease.

Expert panelists from academia, industry, service/product providers, and funding bodies, discussed the utility and application of iPSCs in this space, whilst also talking openly about the challenges that scientists face in using them.

Occurred on: 7^th December 2021

Time: 6pm CET / 5pm GMT / 12pm ET/ 8am PT

Panelists:

• Amy Pooler, VP Neuroscience, Sangamo
• Charlie Arber, Senior Research Fellow, UCL
• Dan Felsenfeld, Director Stem Cell Biology and Regenerative Medicine, CHDI
• Ash Barnes, CSO, Axol Bioscience Ltd